Cumulative Yearly Effects of Raloxifene on the Risk of Vertebral Fractures and Invasive Breast Cancer in Postmenopausal Women with Osteoporosis

被引：0
|
作者：
Wong, Mayme [1 ]
Liu, Chunhua [1 ]
Qu, Yongming [1 ]
Helt, Cameron [1 ]
Stock, John L. [1 ]
机构：
[1] Eli Lilly & Co, Womens Hlth, Indianapolis, IN 46285 USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2008年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1226 / 1226
页数：1
相关论文
共 50 条
  • [31] Strontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis
    Reginster, JY
    Lorenc, RS
    Spector, TD
    Benhamou, C
    Isaia, G
    Brixen, K
    Stucki, G
    Prins, J
    Walravens, M
    Cannata, JB
    De Chatel, R
    Meunier, PJ
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S51 - S52
  • [32] Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
    Barrett-Connor, E.
    Mosca, L.
    Collins, P.
    CURRENT CARDIOVASCULAR RISK REPORTS, 2007, 1 (02) : 133 - 136
  • [33] Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
    Barrett-Connor, Elizabeth
    Mosca, Lori
    Collins, Peter
    Geiger, Mary Jane
    Grady, Deborah
    Kornitzer, Marcel
    McNabb, Michelle A.
    Wenger, Nanette K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (02): : 125 - 137
  • [34] Raloxifene reduces the clinical vertebral fracture risk at 1 year in women with osteoporosis without prevalent vertebral fractures
    Qu, Y
    Stock, JL
    Thiebaud, D
    Wong, M
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 809 - 809
  • [35] Teriparatide and Raloxifene Reduce the Risk of New Adjacent Vertebral Fractures in Postmenopausal Women with Osteoporosis Results from Two Randomized Controlled Trials
    Bouxsein, Mary L.
    Chen, Peiqi
    Glass, Emmett V.
    Kallmes, David F.
    Delmas, Pierre D.
    Mitlak, Bruce H.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (06): : 1329 - 1338
  • [36] Effect of raloxifene on invasive breast cancer incidence by baseline breast cancer risk in postmenopausal women at risk for major coronary events.
    Geiger, M. J.
    Song, J.
    Dowsett, S. A.
    Barrett-Connor, E.
    Cauley, J.
    Grady, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S169 - S169
  • [37] Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
    Reginster, JY
    Minne, HW
    Sorensen, OH
    Hooper, M
    Roux, C
    Brandi, ML
    Lund, B
    Ethgen, D
    Pack, S
    Roumagnac, I
    Eastell, R
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 (01) : 83 - 91
  • [38] Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
    J.-Y. Reginster
    H. W. Minne
    O. H. Sorensen
    M. Hooper
    C. Roux
    M. L. Brandi
    B. Lund
    D. Ethgen
    S. Pack
    I. Roumagnac
    R. Eastell
    Osteoporosis International, 2000, 11 : 83 - 91
  • [39] Risk factors for breast cancer in postmenopausal women with osteoporosis
    Cauley, J
    Cummings, S
    Song, J
    Dowsett, S
    Mershon, J
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 794 - 794
  • [40] Does raloxifene reduce postmenopausal women's risk of breast cancer?
    Han, RK
    Pimlott, N
    Heisey, R
    CANADIAN FAMILY PHYSICIAN, 2000, 46 : 77 - +
12345